Gene: CUZD1
Official Full Name: CUB and zona pellucida like domains 1provided by HGNC
Gene Summary: Predicted to be involved in trypsinogen activation. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23358 | CUZD1 Knockout cell line (HeLa) | Human | CUZD1 | 1:3~1:6 | Negative | Online Inquiry |
KO23359 | CUZD1 Knockout cell line (HCT 116) | Human | CUZD1 | 1:2~1:4 | Negative | Online Inquiry |
KO23360 | CUZD1 Knockout cell line (A549) | Human | CUZD1 | 1:3~1:4 | Negative | Online Inquiry |
CUZD1 Gene Knockout Cell Lines are specifically engineered cellular models that have undergone precise genetic modifications to disrupt the expression of the CUZD1 gene. The CUZD1 gene encodes a membrane protein involved in various cellular processes, including adhesion and signaling. By employing CRISPR/Cas9 or similar gene editing technologies, these knockout cell lines serve as invaluable tools for elucidating the functional role of CUZD1 in cellular mechanisms and disease pathways.
The primary function of CUZD1 Gene Knockout Cell Lines is to facilitate research into the gene's involvement in cell behavior, including proliferation, migration, and differentiation. The targeted knockout mechanism ensures that researchers can study the phenotypic outcomes of the loss of CUZD1 expression, enabling a deeper understanding of both normal biology and pathological states such as cancer. This understanding is critical, as CUZD1 is increasingly recognized as a potential biomarker and therapeutic target in various malignancies.
Scientifically, CUZD1 Gene Knockout Cell Lines offer significant advantages in the exploration of gene function, comparative studies, and drug discovery. These cell lines allow for high-throughput screening of pharmacological agents, providing insights into how CUZD1 modulation may influence therapeutic responses. Compared to traditional models, such as wild-type or overexpressing systems, knockout lines provide a clearer and more controlled environment for studying loss-of-function phenotypes.
For researchers, clinicians, and biopharmaceutical developers, the value of CUZD1 Gene Knockout Cell Lines lies in their ability to generate reproducible and relevant datasets that can significantly advance knowledge in cancer biology and treatment avenues. Our company specializes in the creation and maintenance of high-quality genetic models, ensuring that our product offerings are backed by rigorous validation and a commitment to excellence in scientific research. This expertise not only enhances the reliability of your findings but also accelerates your progress in finding innovative solutions for complex biological challenges.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.